Related Experiment Video
Updated: May 5, 2026

06:03
Isolation and Characterization of Microvesicles from Peripheral Blood
Published on: January 6, 2017
26.4K
Isolation of circulating microRNAs from microvesicles found in human plasma
John F Quackenbush1, Pamela B Cassidy, Lawrence M Pfeffer
1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Methods in Molecular Biology (Clifton, N.J.)
|November 22, 2013
Summary
Circulating microRNAs (miRNAs) are stable in blood due to encapsulation in microvesicles, making them promising cancer biomarkers. A new method using ExoQuick resin efficiently isolates these microvesicles from biological fluids for biomarker discovery.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Circulating microRNAs (miRNAs) are remarkably stable in bodily fluids, resisting RNase degradation.
- This stability makes them valuable as diagnostic biomarkers and therapeutic targets for diseases like melanoma.
- miRNAs are protected from degradation by being encapsulated within membrane-bound microvesicles.
Purpose of the Study:
- To describe a convenient method for purifying microvesicles from biological fluids.
- To enable the identification of potential cancer-specific biomarkers using isolated microvesicles.
Main Methods:
- Utilized ExoQuick, a proprietary resin from Systems Biosciences, for microvesicle purification.
- Employed gentle conditions and readily available laboratory equipment for the isolation protocol.
- The method isolates all microvesicles, irrespective of their cellular origin.
Main Results:
- Demonstrated a convenient protocol for microvesicle isolation from serum and plasma.
- The method preserves the integrity of encapsulated miRNAs.
- Facilitates the discovery of novel cancer biomarkers.
Conclusions:
- ExoQuick provides an efficient and accessible method for microvesicle isolation.
- This technique supports the development of non-invasive diagnostic tools for cancer.
- Circulating microvesicles are a rich source for identifying cancer biomarkers.

